Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Immunology | Dermatology | Infections and Infectious Diseases | Family Medicine
Genital Warts Clinical Trials
A listing of Genital Warts medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
California
Alhambra : Call for Information (Investigational Site 0238)
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
Roseville : Call for Information (Investigational Site 0236)
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
Spring Valley : Call for Information (Investigational Site 0237)
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
Florida
Coral Gables : Call for Information (Investigational Site 0250)
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
Miami : Call for Information (Investigational Site 0248)
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
South Miami : Call for Information (Investigational Site 0247)
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
Tampa : Call for Information (Investigational Site 0026)
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
Indiana
Indianapolis : Call for Information (Investigational Site 0233)
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
Kentucky
Bardstown : Call for Information (Investigational Site 0228)
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
Louisiana
Marrero : Call for Information (Investigational Site 0249)
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
Maryland
Elkridge : Call for Information (Investigational Site 0242)
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
Missouri
Kansas City : Call for Information (Investigational Site 0229)
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
New York
New York : Call for Information (Investigational Site 0264)
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
Rochester : Call for Information (Investigational Site 0241)
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
Ohio
Cincinnati : Call for Information (Investigational Site 0231)
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
Pennsylvania
Philadelphia : Call for Information (Investigational Site 0240)
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
Philadelphia : Call for Information (Investigational Site 0025)
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
Tennessee
Nashville : Call for Information (Investigational Site 0232)
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
Texas
Galveston : Call for Information (Investigational Site 0255)
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
Utah
Salt Lake City : Call for Information (Investigational Site 0235)
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
Virginia
Richmond : Call for Information (Investigational Site 0245)
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
Canada
Kirkland : Merck Frosst Canada Ltd.
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
Colombia
Bogota : MDS Colombia SAS
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
Denmark
Glostrup : Merck Sharp & Dohme
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
Germany
Haar : MSD Sharp & Dohme GMBH
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
Israel
Hod Hasharon : Merck Sharp & Dohme Co. Ltd.
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
Malaysia
Petaling Jaya : MSD
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
Norway
Drammen : MSD (Norge) AS
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
Poland
Warszawa : MSD Polska Sp. Z o.o.
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
Spain
Madrid : Merck Sharp and Dohme de Espana S.A.
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
Sweden
Sollentuna : MSD
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
Taiwan
Tainan : National Cheng Kung University Hospital
SR-T100 Gel Efficacy & Safety Study for Vulva Pre-cancerous Lesions & Cutaneous Condyloma
